Thomas Flaten
Stock Analyst at Lake Street
(0)
# 4149
Out of 5,253 analysts
38
Total ratings
32.14%
Success rate
-4.88%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
OptiNose | Maintains: Buy | 45 17 | 6.31 | 169.41% | 4 | Jan 16, 2025 | |
Personalis | Maintains: Strong Buy | 7 9 | 5.47 | 64.53% | 2 | Jan 8, 2025 | |
Checkpoint Therapeut... | Maintains: Strong Buy | 4 7 | 2.84 | 146.48% | 4 | Dec 16, 2024 | |
Castle Biosciences | Maintains: Strong Buy | 34 40 | 26.76 | 49.48% | 5 | Nov 5, 2024 | |
Journey Medical | Initiates Coverage On: Buy | 9 | 3.98 | 126.13% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1 | n/a | n/a | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 0.81 | 270.37% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 8 | 3.12 | 156.41% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 11 | 3.01 | 265.45% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 25 | 28.47 | -12.19% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 1800 700 | 4.72 | 14730.51% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 60 10 | 2.04 | 390.2% | 4 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14400 1440 | 7.59 | 18872.33% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 8 | 5.95 | 34.45% | 1 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | May 13, 2022 |